The MedicX Fund Limited Securities allotted from Block Listing (0411I)
17 March 2018 - 2:38AM
UK Regulatory
TIDMMXF
RNS Number : 0411I
The MedicX Fund Limited
16 March 2018
For immediate release
16 March 2018
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Securities allotted from Block Listing
MedicX Fund Limited (LSE: MXF), announces in accordance with
Listing Rule 3.5.6R the number of securities allotted over the six
month period pursuant to the block listing of 14,771,668 ordinary
shares of no par value admitted to The Official List of the UK
Listing Authority on 14 August 2017.
Name of applicant: MedicX Fund Limited
----------------------------------------------------------------------------------- ---------------------------------
Name of scheme: Block Listing
----------------------------------------------------------------------------------- ---------------------------------
Period of return: From: 19/09/2017 To: 16/03/2018
--------------------------------------------------------- ------------------------ ------------- ---- ------------
Balance of unallotted securities under scheme(s) from previous return: 14,771,668
----------------------------------------------------------------------------------- ---------------------------------
Plus: The amount by which the block scheme(s) has been increased since the date of Nil
the last
return (if any increase has been applied for):
----------------------------------------------------------------------------------- ---------------------------------
Less: Number of securities issued/allotted under scheme(s) during period (see Total allotted - Nil
LR3.5.7G):
----------------------------------------------------------------------------------- ---------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of period: Total remaining - 14,771,668
----------------------------------------------------------------------------------- ---------------------------------
Name of contact: Alan Pennell
------------------------------ --------------
Telephone number of contact: 0203 142 4813
------------------------------ --------------
- End -
For further information please contact:
Octopus Healthcare Adviser Limited +44 (0) 345 0404 5555
Octopus Healthcare Group +44 (0) 20 3142 4820
Mike Adams, Chief Executive Officer
Canaccord Genuity +44 (0) 20 7523 8000
Andrew Zychowski/Helen Goldsmith
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Vicky Hayns
Information on MedicX Fund Limited
MedicX Fund Limited (the "Fund" or the "Company", or together
with its subsidiaries, the "Group") is the specialist primary care
infrastructure investor in modern, purpose-built primary healthcare
properties in the United Kingdom and Ireland, listed on the London
Stock Exchange, with a portfolio comprising 153 properties.
The Investment Adviser to the Company is Octopus Healthcare
Adviser Ltd, which is part of the Octopus Healthcare group. Octopus
Healthcare invests in and develops properties as well as creating
partnerships to deliver innovative healthcare buildings to improve
the health, wealth and wellbeing of the UK. It currently manages
over GBP1.2 billion of healthcare investments across a number of
platforms, with a focus on five core areas: GP surgeries, care
homes, special education schools, retirement housing and private
hospitals. Octopus Healthcare is part of the Octopus group, a
fast-growing UK fund management business with leading positions in
several specialist sectors including healthcare property, energy,
property finance and smaller company investing. Octopus manages
GBP7 billion of funds for more than 50,000 retail and institutional
investors as well as supplying energy to more than 100,000
customers
Octopus Healthcare Adviser Ltd is authorised and regulated by
the Financial Conduct Authority.
The Company's website address is www.medicxfund.com. Neither the
contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website (or any other
website), nor the contents of any website accessible from
hyperlinks within this announcement, are incorporated into, or
forms part of, this announcement.
The Company's Legal Entity Identifier is
2138008POF35FTNFCB25
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRFMGMFKVKGRZM
(END) Dow Jones Newswires
March 16, 2018 11:38 ET (15:38 GMT)
Medicx (LSE:MXF)
Historical Stock Chart
From Apr 2024 to May 2024
Medicx (LSE:MXF)
Historical Stock Chart
From May 2023 to May 2024